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ABSTRACT
The objective of this randomized clinical trial was 
to determine if an intervention with colostrum replacer 
(CR; Premolac Plus, Zinpro; 125 g/d fed for 3 d) or 
a placebo milk replacer (Cows Match, Land O’Lakes 
Inc.; 125 g/d for 3 d) following a triggered alarm could 
ameliorate disease bouts in dairy calves. The alarm was 
set to detect negative deviations of milk intake (20% 
reduction) or drinking speed (30% reduction) in rela-
tion to a calf’s 12-d rolling average feeding behavior. 
Calves were enrolled on this study (n = 42 CR, n = 
42 placebo) when they triggered an alarm from d 14 
to 50 on the feeder before weaning. Once calves were 
enrolled, calves received a bottle of either 125 g of CR 
or milk replacer mixed with 1 L of water for 3 d. Calves 
were enrolled on the automated milk feeder at age 4.0 
± 2.0 d (mean ± SD), were offered 10 L/d of the same 
milk replacer fed as a placebo, and had ad libitum ac-
cess to calf starter measured by automated feeders. 
Weaning began at d 50, with 50% reduction of milk 
replacer across 14 d, and an additional 20% reduction 
for another 7 d before weaning at d 70. Calves were 
health scored from birth to 2 wk postweaning (88 ± 
2.0 d of age) daily for bovine respiratory disease (BRD) 
and diarrhea, and were weighed and scored using lung 
ultrasonography twice weekly. A BRD score ≥5 and 
an area of consolidated lung ≥3.0 cm2 was considered 
BRD positive; diarrhea was defined as a watery fecal 
consistency that sifted through the bedding. The effect 
of CR on BRD and diarrhea likelihood were calculated 
with logistic models; the 7 d before and after an alarm 
were fixed effects, with milk intake as a covariate. A 
Cox proportional hazards model evaluated the effect of 
CR on the hazard of being positive for BRD and diar-
rhea following enrollment, with sex as a fixed effect in 
the diarrhea model. The effect of CR on average daily 
gain the week following intervention was evaluated with 
linear modeling with repeated measures, and birth date 
was a random effect. After intervention, placebo calves 
had 1.64 (95% CI: 1.11–2.43) times greater odds of hav-
ing a BRD bout compared with CR calves for the 7 
d following intervention. Moreover, placebo calves had 
1.50 (95% CI: 1.11–2.08) times greater odds of having 
lobar lung consolidation in the 7 d after intervention 
than CR calves. No difference was found in the likeli-
hood of diarrhea in the 7 d after intervention (odds ra-
tio: 0.91; 95% CI: 0.71–1.16). However, placebo calves 
had a 2.38 (95% CI: 1.30–4.33) times greater hazard 
of incurring BRD in the 14 d after intervention. Aver-
age daily gain was not associated with an intervention 
with CR for the 7 d after intervention (placebo: 0.73 ± 
0.07 kg/d; CR: 0.70 ± 0.08 kg/d; LSM ± SEM). These 
results suggest CR may reduce BRD likelihood but did 
not influence growth in calves offered high allowances 
of milk. Future research should examine which proper-
ties of CR ameliorate BRD in calves.
Key words: bovine respiratory disease, diarrhea, 
growth, preweaning, supplement
INTRODUCTION
Bovine respiratory disease complex (BRD) and diar-
rhea are significant causes of morbidity in dairy calf 
operations, and disease mitigation may increase farm 
efficiency. According to a national producer survey, 
BRD and diarrhea affected 33% of preweaned dairy 
calves, with a high majority of affected calves receiving 
antibiotics (BRD 95% and diarrhea 76%; USDA 2018). 
It is essential to mitigate disease as the preweaning pe-
riod is the most economically intensive for heifer raising 
operations (Hawkins et al., 2019). For example, BRD 
was estimated to cost $42/calf (Dubrovsky et al., 2020) 
and treatment for diarrhea was estimated to cost a 
median of $56/calf (Goodell et al., 2012). Furthermore, 
in the short term BRD (i.e., lung consolidation on ul-
trasound) was associated with lower preweaning ADG 
(Cramer and Ollivett, 2019). In the long term, BRD 
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at weaning was associated with lower milk production 
during the first lactation (Dunn et al., 2018) and a 
lower hazard of pregnancy, coupled with a lower hazard 
of producing milk in the first lactation (Teixeira et al., 
2017). Similarly, diarrhea identified preweaning was as-
sociated with a lower hazard of pregnancy (Aghakesh-
miri et al., 2017). Therefore, it is of interest to mitigate 
incidence of BRD and diarrhea. Moreover, lowering the 
duration of disease will improve calf welfare because 
disease is metabolically costly and potentially painful 
for calves.
The dairy industry is under pressure to lower reli-
ance on antibiotics, particularly for subtherapeutic use 
(as reviewed by Placzek et al., 2020); thus, alternative 
therapies should be considered for mitigating disease 
risk in calves. One potential alternative therapy is the 
use of nutraceuticals, which are nutritional interven-
tions thought to have positive effects on physiological 
status and health outcomes (as reviewed by Nasri et al., 
2014). For example, colostrum may be a nutraceutical 
intervention for calves, as it has a high immunoglobulin 
and lactoferrin content (Giansanti et al., 2016) and 
anti-inflammatory properties (Lee et al., 2019). Inter-
estingly, first-milking bovine colostrum has been used 
as a preventative nutraceutical to ameliorate disease in 
human medicine and is considered a common practice 
(as reviewed by Alexieva et al., 2011, and Bagwe et al., 
2015). Similar immune improvement has been observed 
in parallel in other species: immunocompromised mice 
(Menchetti et al., 2020), weaned piglets (Boudry et al., 
2007), and dogs vaccinated for distemper (Satyaraj et 
al., 2013). Moreover, 100 young Thoroughbred horses 
fed a colostrum nutraceutical at (50 g/d) for 4 mo 
ameliorated disease duration (2 wk) versus soy flour 
controls (4 wk: Fenger et al., 2016). Thus, bovine co-
lostrum as a nutraceutical may improve immune status 
in other species. To date, there is no work that has 
investigated the efficacy of colostrum nutraceuticals 
as an intervention strategy for dairy calves at risk for 
disease. However, there is literature that suggests feed-
ing colostrum to healthy dairy calves as a longer-term 
preventative feeding strategy may improve calf health 
outcomes.
There is preliminary evidence that healthy dairy 
calves benefit from the preventative feeding, or ex-
tended feeding, of colostrum as a nutraceutical. For 
example, calves fed colostrum replacer (150 g/d) dur-
ing the first 14 d of life had lower odds of abnormal 
feces or abnormal respiration, and decreased odds of 
receiving antibiotics (Chamorro et al., 2017). Different 
results were observed at a lower dosage, where 30 calves 
receiving a colostrum nutraceutical at 70 g/d had a 
lower likelihood of diarrhea, and a decreased likelihood 
of receiving antibiotics, but the odds of developing 
BRD were not different (Berge et al., 2009). Moreover, 
a recent study observed that partially replacing the 
milk diet with different levels of colostrum at up to 
700 g/d reduced the odds of diarrhea, improved perfor-
mance, and tended to reduce the risk of BRD (Kargar 
et al., 2020). Similarly, there is evidence that extended 
colostrum feeding for the first 21 d of life decreased 
BRD morbidity for the first year of life and decreased 
diarrhea risk, whereas milk production was higher for 
extended colostrum-fed calves during the first lacta-
tion (Armengol and Fraile, 2020). Hence, there is the 
potential for colostrum to ameliorate disease in dairy 
calves when fed as a preventative therapy. However, it 
is unknown if colostrum can be used as an intervention 
feeding strategy to mitigate disease risk in calves.
One limitation to feeding a colostrum nutraceutical 
across an extended period is cost. Therefore, it is of 
interest to determine if an intervention provided to a 
calf during early signs of disease development can lower 
disease likelihood and ameliorate disease bouts. Auto-
mated milk feeding systems, which measure and record 
feeding behavior of dairy calves, are able to detect 
deviations in feeding behavior that have been associ-
ated with disease development (Knauer et al., 2017; 
Sutherland et al., 2018). Therefore, the objective of this 
study was to determine if intervention with one dose of 
a colostrum replacer (CR) nutraceutical fed across 3 d 
(125 g of CR mixed with 1 L of water by bottle) versus 
a control milk replacer (125 g mixed with 1 L of water 
by bottle), offered to calves that triggered an auto-
mated feeder alarm detected by the default automated 
feeder algorithm could ameliorate disease bouts (BRD 
and diarrhea), reduce the odds of disease, and improve 
performance (ADG) in calves offered intermediate 
levels of milk (10 L/d) for 50 d. We chose deviations 
in feeding behavior as an intervention point because 
an epidemiological study found an association between 
negative deviations in feeding behavior up to 4 d before 
disease in calves fed by automated feeders (Knauer et 
al., 2017). We hypothesized that CR would ameliorate 
disease bouts (BRD and diarrhea), and reduce the odds 
of disease in calves, but would not affect performance.
MATERIALS AND METHODS
This study was conducted at the University of Ken-
tucky Coldstream Research Dairy Farm in Lexington, 
KY from July 2018 to August 2019. This facility was 
selected for the availability of dairy calves with a high 
prevalence of passive transfer in the herd (90%), and 
due to the ability to blind farm staff to treatment as-
signments for this study. A total of 120 calves were 
selected for this trial, of which 84 calves (placebo = 
42; CR = 42) met the following enrollment criteria: 
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removed from dam within 6 h and fed maternal colos-
trum, had a serum BRIX of 8.4% at 48 h of life as a 
passive transfer threshold (Deelen et al., 2014), were 
not a twin, and triggered an alarm on the automated 
milk feeder between feeder d 14 to 50. All calves en-
rolled were part of the Institutional Animal Care and 
Use Committee approval number 2018: 2864.
Management and Feeding
Calves were randomly assigned (www .random .org) by 
due date in groups of 10 to receive an intervention with 
either 1 dose (375 g, given as 125 g/d for 3d) containing 
150 g of IgG CR (Premolac Plus, Zinpro; % DM basis 
minimum 70% CP, and maximum 8% fat, 0.2% crude 
fiber, 10% ash, and contained 4.65 Mcal of ME/kg) 
or placebo milk replacer (Cows Match, Land O’Lakes 
Inc.). Milk replacer on a percentage DM basis was a 
minimum 28% CP, 20% fat, a maximum 15% crude 
fiber, a minimum 1.0% calcium and 0.70% phosphorus, 
and contained 4.87 Mcal of ME/kg. The treatment dose 
was fed at 1100 h by bottle to calves that received an 
alarm that morning detected by an automated milk 
feeder (AMF; Forster-Technik); the 2 researchers were 
not blind to treatment, as the bottles needed to be 
prepared across 3 d (125 g/d in 1 L of water). Similarly, 
the calves received the placebo dose of milk replacer by 
bottle for 3 d (125 g/d in 1 L of water).
No study has investigated the ability of a colostrum 
intervention to reduce BRD incidence in calves. Thus, 
we powered this study based on true herd BRD inci-
dence (60%) calculated before the study with a 10% 
reduction in disease; we considered 10% to be the mini-
mum disease reduction required for colostrum to be 
considered as a potential nutraceutical intervention. A 
power analysis showed that a total of 84 calves (n = 
42 per treatment) was required at 80% power to detect 
a 10% BRD incidence difference, with half-widths at 
0.05, and true herd BRD incidence at 60%. Our power 
analysis for ADG showed that a total of 62 calves (n 
= 31 per treatment) were required for calves offered 10 
L/d in an AMF at an average ADG 0.67 kg/d, with a 
variation of 0.07 kg/d, as was observed in the literature 
(Rosenberger et al., 2017). The power analysis for ADG 
projected a targeted difference of 0.05 kg/d between 
treatments in ADG for feeding CR at 80% power, and 
half-widths at 0.05. The true herd incidence for BRD 
was calculated by one trained researcher health scoring 
all newborn calves from birth until 2 wk postweaning 
twice weekly for 9 mo using the UW Calf Health Scoring 
System to define a new BRD case (48/80 BRD calves; 
McGuirk and Peek, 2014) before this study. The AMF 
algorithm that was used was the default manufacturer 
alarm programmed into the automated calf feeder. The 
AMF algorithm generated a baseline feeding behavior 
average for milk intake, and for drinking speed, based 
on the rolling 12 d average for each calf. The AMF 
triggered an alarm when a calf deviated in milk intake 
(20% reduction) or drinking speed (30% reduction) 
from this rolling baseline average. Calves could trigger 
an AMF alarm from feeder d 14 to 50.
Calves were removed from the dam within 6 h after 
birth and placed in individual pens (3 × 3 m) bed-
ded with sawdust and were weighed using an electronic 
scale (Brecknell PS1000, Avery Weigh-Tronix LLC) 
weighing 40.08 ± 5.46 kg (mean ± SD) at birth. Calves 
were fed 6 L/d of 840 g milk replacer (Cow’s Match; 
Land O’Lakes Animal Milk Products Co.) by bottle, di-
vided into 2 feedings when housed individually. Calves 
were enrolled on the AMF when a strong suckle reflex 
was present at an average age of 4.0 ± 2.0 d and placed 
in a group pen (4.57 × 10.67 m) containing 6 ± 3 
other calves and bedded with sawdust shavings. Pens 
were cleaned, emptied, and bedding was removed and 
sanitized every 2 wk. To ensure calves in a pen were of 
similar size and age, calves were moved to an identi-
cal adjacent pen with the same stocking density using 
dynamic flow at an average age of 45.0 ± 3.0 d before 
weaning.
Calves were fed the first meal with human assistance 
on the AMF and received human assistance every 12 
h (maximum learning duration 4 feedings) until inde-
pendent milk consumption was observed. Calves were 
allotted up to 10 L (140 g/L) of milk replacer per day 
from the AMF (Cow’s Match; Land O’Lakes Animal 
Milk Products Co.) for 50 d. A step-down gradual 
weaning procedure was performed at d 51 where milk 
allowance was reduced to 50% allotment for 14 d, and 
then reduced to 20% allotment for an additional 7 d 
until complete weaning at 70 d. Calves were followed 
for 14 d postweaning.
The automated calf starter feeder contained a 22% 
CP calf starter feed (Calf Starter; Baghdad Feeds). 
Calves were also offered chopped alfalfa hay in a trough 
(1.83 × 0.33 × 0.16 m). Both the AMF and the calf 
starter feeder were calibrated weekly according to 
manufacturer instructions. All calves had ad libitum 
access to water, calf starter, and chopped alfalfa hay 
during the study period.
Health Exams
Calves were scored daily beginning at birth to 2 wk 
postweaning at 88 ± 2.0 d of age by 1 of 3 observ-
ers (interobserver agreement κ > 0.90) for BRD using 
the UW Calf Health Chart (McGuirk and Peek, 2014), 
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which assigns and sums the nasal discharge score, eye 
discharge score, ear tilt score, cough score, and temper-
ature score. Moreover, calves were rectally stimulated 
daily for fecal consistency assessment (interobserver 
agreement κ > 0.95). Calf fecal consistency scoring 
scale was: 1 soft (does not hold form, piles but spreads 
slightly), 2 runny (spreads readily), and 3 watery (liq-
uid consistency, splatters), a score of 3 was considered 
diarrhea (Renaud et al., 2020).
The interobserver agreement for health scoring was 
measured using Fleiss’ kappa every 4 mo throughout the 
study by having all observers go to a commercial facil-
ity on the same day to score 40 calves where the health 
status of the calves was unknown to ensure unbiased 
agreement. Similarly, 12 calves enrolled on a separate 
study and kept in a separate pen at this facility (Wood-
rum Setser et al., 2020) were evaluated for interobserver 
agreement for health scoring twice. Similarly, the calves 
from (Woodrum Setser et al., 2020) were scored using 
lung ultrasonography by 2 observers on one morning, 
and euthanized that afternoon (euthanasia was part of 
the study protocol); the lungs were retrieved and scored 
by a researcher blind to the researcher’s scores to con-
firm that the 2 observers diagnosed lung lobe status 
accurately (interobserver agreement Cohens’ kappa; κ 
= 0.90).
Weights were collected twice weekly using the same 
scale used to weigh calves at birth. Lung ultrasounds 
were collected twice weekly using 70% isopropyl alcohol 
as a transducing agent and by evaluating 5 lung lobes 
in each calf with 1 of 2 observers (interobserver agree-
ment Cohens’ kappa; κ = 0.90) with a portable linear 
rectal ultrasound (Buczinski et al., 2018). In brief the 
ultrasound was set to a depth of 9 cm, frequency of 6.2 
MHz, and gain of 23 dB (near 13 dB; far 36 dB; Ibex 
Pro, E.I. Medical). A BRD score ≥5 and lobar consoli-
dation in any one lung lobe ≥3.0 cm2 was considered a 
BRD bout, as described in (Buczinski et al., 2018). All 
calves with a positive BRD bout received enrofloxacin 
subcutaneously with dosage calculated by BW (Baytril, 
Bayer; 1 mL/15 kg) according to the herd veterinarian 
protocol. Calves who failed to respond to BRD bout 
antibiotic treatment were not retreated until 14 d after 
the first treatment. Calves who failed to repond to an-
tibiotic treatment were classified as a new BRD bout 
on d 15 if calves had an average BRD score ≥5 from 
d 10 to 14 after antibiotic treatment and at least one 
lung lobe consolidation at ≥3.0 cm2. Failure-to-respond 
calves were treated with tulathromycin (Draxxin, Zo-
etis Animal Health; 1 mL/45 kg, once at diagnosis, 
subcutaneously). Every health exam also included pal-
pation of the umbilical site and was graded as a score of 
zero (closed), 1 (open, normal), or 2 (swelling, clouded 
discharge infection; following Cantor et al., 2019). Only 
one calf presented with an umbilical infection and was 
eliminated from this study and not enrolled. 
Statistical Analysis
All statistical methods were carried out in SAS ver-
sion 9.4 (SAS Institiute). Initially, descriptive statistics 
and residual diagnostics assessed the relationship with 
all outcomes reported at the univariable level, using a 
cutoff of P < 0.20 for inclusion in the model. Normality 
was confirmed by visual assessment of residuals in the 
model using quartile plots.
The t-tests (Proc Ttest) were used to confirm there 
was no difference between treatments for health status, 
weight, and feeding intake (milk and calf starter) on the 
day before triggering the alarm, and differences in feed 
intake in the week after the alarm were also assessed.
Efficacy of CR on Ameliorating Disease. The 
effect of CR to ameliorate a BRD bout was calculated 
with a logistic model (PROC Logistic) utilizing the 7 
d before and after an alarm as fixed effects, with milk 
intake as a covariate. The effect of CR to ameliorate 
a diarrhea bout was calculated with a logistic model 
(PROC Logistic) utilizing the 7 d before and after an 
alarm as fixed effects, with milk intake as a covariate.
Effect of CR on Survival from a Disease Bout. 
A survival analysis using Breslow methods (PROC 
Lifetest) was performed to determine if treatment 
intervention affected the hazard of being positive for 
a BRD bout in the 14 d following treatment. Calves 
were classified as healthy at 15 d if they were never 
diagnosed with a BRD bout. A survival analysis us-
ing Breslow methods was also performed to determine 
if treatment intervention affected the hazard of being 
positive for a diarrhea bout in the 14 d following treat-
ment. Calves were classified healthy at 15 d if they were 
never diagnosed with a diarrhea bout.
Effect of CR on Odds of a Disease Bout. A Cox 
proportional hazards model (PROC Hazard) evaluated 
the effect of CR on the hazard of a BRD bout using the 
Nelson-Aalen cumulative hazard method. Nelsen-Aalen 
cumulative hazards were used because the probability 
of survival from a disease bout generated in these calves 
was for a short duration of 14 d. A Cox proportional 
hazards model also evaluated the effect of CR on the 
hazard of a diarrhea bout with sex as a fixed effect 
using the Nelson-Aalen cumulative hazard method. In 
the Cox proportional hazards model, proportionality 
assumption was tested graphically using log-log plots. 
No outliers were found in any of the models.
Effect of CR on Improving Performance. The 
effect of CR on the ADG during the 7 d after the in-
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tervention was determined using a mixed linear model 
(PROC Mixed) with dam parity, feed intake, and BRD 
status as covariates, repeated by day, calf as a subject, 
and birth date as a random effect. Sex was evaluated 
for its association with ADG, but it was not significant 
and was removed from the model. The effect of CR 
on ADG for the 2 wk postweaning was also evaluated 
with a mixed linear model, with BRD status and calf 
starter intake as covariates, repeated by day and calf. 
To ensure outliers did not have leverage, standardized 
residuals were plotted against predicted outcomes to 
assess for model leverage, though no extreme outliers 
were identified.
RESULTS
Descriptive Statistics
A total of 120 calves were followed, but 2 calves did 
not meet enrollment criteria (failed transfer of passive 
immunity), 1 calf had an umbilical infection before en-
rollment, and 27 calves never triggered an alarm from d 
14 to 50. There were 6 calves (3 placebo and 3 CR) that 
refused the bottle on one of the 3 d of intervention, and 
thus, these 6 calves were not enrolled in the analysis 
due to failure to complete the treatment. A total of 84 
calves with 14 bulls and 28 heifers per treatment (CR 
= 42; placebo = 42) triggered an alarm from the AMF 
(112 alarms), drank the offered treatment on all 3 d, 
and were assigned to a treatment group (n = 59 alarms 
to placebo, n = 53 alarms to CR). Only the first alarm 
for each calf was considered for all health outcomes 
(42 placebo and 42 CR calves). Treatment groups did 
not differ on the day before alarm for health status 
(BRD: 4 placebo, 3 CR; diarrhea: 14 placebo, 13 CR), 
or BW [placebo: 56.34 ± 2.31 kg; CR: 57.19 ± 2.20 kg 
(mean ± SE); P > 0.10]. Similarly, health status was 
not different on the day the alarm was triggered, and 
no new cases of BRD or diarrhea were present. Calf 
age was also not different on the day the alarm was 
triggered (placebo: 31.63 ± 1.67 d; CR: 32.51 ± 1.67 
d; P > 0.10). Similarly, average milk intake on the day 
before the alarm was not different between treatments 
(placebo: 7.91 ± 0.23 L; CR: 7.87 ± 0.29 L; P > 0.10). 
Calf starter intake was also not different between treat-
ments on the day before the alarm (placebo: 0.15 ± 
0.06 kg; CR: 0.18 ± 0.04; P > 0.10).
For the week after treatment intervention, milk intake 
was not different between treatments (placebo: 8.17 ± 
0.11 L/d; CR: 8.18 ± 0.10 L; P > 0.10) but calf starter 
intake was greater for CR calves (placebo: 0.16 ± 0.02 
kg/d; CR: 0.28 ± 0.02 kg/d; P < 0.001). Similarly, 
calf starter intake postweaning was different between 
treatments (placebo: 3.52 ± 0.09 kg/d; CR: 4.08 ± 0.10 
kg/d; P < 0.001).
Efficacy of CR on Ameliorating Disease
Calves in the placebo group had 1.64 (95% CI: 1.11–
2.43; P = 0.01) times greater odds of being positive for 
BRD compared with CR calves for the 7 d following in-
tervention (18 placebo calves vs. 11 CR calves). More-
over, placebo calves had a 1.50 (95% CI: 1.15–2.08; P = 
0.01) times greater odds of having lobar lung consolida-
tion than CR calves for the 7 d following intervention 
(21 placebo calves vs. 14 CR calves). No difference was 
found in the likelihood of diarrhea between groups for 
the 7 d following treatment intervention (OR 0.91; 95% 
CI: 0.71–1.16; P > 0.10; 11 placebo calves and 12 CR 
calves).
Effect of CR on Disease Bout: Survival
BRD Complex. A BRD bout was defined as a calf 
developing at least lobar lung consolidation ≥3.0 cm2 
and a BRD score of ≥5. Placebo calves had 2.38 times 
(95% CI: 1.30–4.33) higher hazard of incurring a BRD 
bout in the 14 d after intervention compared with CR 
calves (P = 0.001). Treatment intervention evaluated 
by Breslow survival curves for the 14 d after treatment 
were significantly different (Figure 1; P = 0.001). For 
example, the first quartile (25%) of placebo calves were 
already positive for BRD by d 3 (95% CI: 1–5), and 
placebo calves were positive for BRD on average at 7.50 
± 0.82 d (mean ± SE) after treatment. In contrast, the 
first quartile of CR calves was positive for BRD later at 
d 7 (95% CI: 5–8) and CR calves were positive for BRD 
on average at 10.51 ± 0.63 d after treatment. More-
over, a placebo calf’s Nelson-Aalen cumulative hazard 
of having BRD by d 14 was 1.09 ± 0.22 (±SE), and the 
Breslow survival probability of remaining healthy on 
d 13 was 0.33. Alternatively, a CR calf’s Nelson-Aalen 
cumulative hazard of having BRD by d 13 was 0.50 ± 
0.12, and the Breslow survival probability of remaining 
healthy was 0.60. The proportion of calves who were 
positive for BRD in the 14 d after intervention is sum-
marized in Table 1.
Diarrhea. The hazard of incurring diarrhea in the 
14 d postintervention was not different by treatment 
intervention (P = 0.18). Similarly, the treatment inter-
vention survival curves for the after treatment interven-
tion had overlapping Hall-Welner confidence interval 
bands and were not significantly different (Figure 2; P 
= 0.16). For example, the first quartile of calves was 
positive for diarrhea by d 3 for placebo (95% CI: 2–5), 
and d 4 for CR (95%: CI 3–7). Nearly all calves had a 
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diarrhea event (Table 2); the Nelson-Aalen cumulative 
hazard of a diarrhea bout by d 9 was placebo 0.84 ± 
0.18 (±SE), and CR 0.70 ± 0.15.
Effect of CR on Improving Performance
The final weight of calves 2 wk postweaning was 
104.1 ± 18.17 kg (mean ± SD) for placebo and 104.3 ± 
18.78 kg for CR. Average daily gain was not affected by 
treatment intervention for the 7 d following interven-
tion (placebo 0.73 ± 0.07 kg/d and CR 0.70 ± 0.08 
kg/d; P > 0.10; LSM ± SEM). The ADG for calves 
from birth to 90 d of age (2 wk postweaning) was also 
not different by treatment (placebo 1.12 ± 0.11 kg/d 
and CR 0.96 ± 0.11 kg/d; P > 0.10). Similarly, ADG 
was not associated with treatment intervention for the 
2 wk postweaning (placebo 1.26 ± 0.08 kg/d and CR 
1.17 ± 0.08 kg/d; P > 0.10).
DISCUSSION
The objective of this study was to determine if we 
could ameliorate BRD or diarrhea bouts, reduce the 
odds of these diseases, and improve performance by 
feeding a CR intervention to preweaned calves who 
triggered a feeding behavior alarm. We found that CR 
may serve as a nutraceutical for preweaned calves, as it 
reduced the hazard of a BRD bout, and increased the 
probability of remaining healthy 15 d after interven-
tion. However, we did not observe any effect of CR 
intervention on ameliorating diarrhea or improving per-
formance. To our knowledge, this is the first study to 
evaluate the effect of early intervention of a CR nutra-
ceutical in response to a change in a feeding behavior 
alarm. Early intervention with CR may improve calf 
welfare as BRD is one of the leading causes of mortality 
in preweaned calves (Dubrovsky et al., 2019). Similarly, 
BRD is economically costly to treat (Dubrovsky et al., 
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Figure 1. Breslow survival probability estimates (P < 0.01) with 
number of subjects (n = 84; 42 colostrum replacer, 42 placebo) at 
risk for a bovine respiratory disease bout. Day 0 represents when an 
automated feeder alarm (negative deviation in baseline milk intake or 
drinking speed) was detected for a calf. All calves received 125 g of 
either milk replacer (placebo) or colostrum replacer in 1 L of water for 
3 d. Day 15 represents calves that remained healthy.
Table 1. Proportion of preweaned group-housed calves (n = 84) with a bovine respiratory disease (BRD) bout 
14 d following treatment after triggering a health alarm on automated feed system for negative deviations in 
milk intake or drinking speed1
Stratum  Treatment2 Total Failed Censored Censored, %
1 Placebo 42 29 13 31.0
2 CR 42 17 25 59.5
Total  84 46 38 45.2
1Censored calves remained healthy at 15 d, and failed calves were diagnosed with a BRD bout within 14 d 
following intervention.
2Placebo = 125 g of placebo milk replacer (Cows Match, Land O’Lakes Inc.) in 1 L of water for 3 d; CR = 125 
g of colostrum replacer (Premolac Plus, Zinpro) in 1 L of water for 3 d.
Figure 2. Breslow survival probability estimates (P < 0.01) with 
number of subjects (n = 84; 42 colostrum replacer, 42 placebo) at 
risk for a diarrhea bout. Day 0 represents when an automated feeder 
alarm (negative deviation in baseline milk intake or drinking speed) 
was detected for a calf. All calves received 125 g of either milk replacer 
(placebo) or colostrum replacer in 1 L of water for 3 d. Day 15 repre-
sents calves that remained healthy.
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2020), and negatively affects ADG (Cramer and Ol-
livett, 2019) and future milk production (Dunn et al., 
2018).
There was a preventative benefit of reducing the 
odds of BRD in calves treated with CR. Although we 
fed our calves for a short duration, our results agree 
with the literature that fed bovine colostrum for an 
extended period of several days. For example, colos-
trum as a nutraceutical decreased the likelihood and 
duration of respiratory disease in calves (Chamorro 
et al., 2017), and ameliorated duration of respiratory 
infection in juvenile racehorses (Fenger et al., 2016). 
Specifically in calves, research has shown feeding 150 
g/d colostrum to younger calves from d 0 to 14 d of age 
reduced the likelihood of BRD before weaning (Cham-
orro et al., 2017). Moreover, a more recent, long-term 
study observed that extended feeding of colostrum for 
21 d reduced BRD risk for the first year of life, and in-
creased first lactation milk production (Armengol and 
Fraile, 2020). However, a recent study that partially 
replaced the milk diet with colostrum from birth until 
14 d (doses included 0, 350, or 700 g/d), found only a 
tendency for BRD to be lower in calves (Kargar et al., 
2020). We suspect Kargar et al., (2020) only found a 
tendency due to a low observed prevalence of BRD in 
their population of calves. In general, our results agree 
with the literature in calves and in other species that 
colostrum may reduce the risk of respiratory ailments. 
However, in this study, we did not evaluate the effect 
of colostrum replacer on the severity of lobar consoli-
dation as we were not powered for magnitude effects. 
Future research should determine which component in 
colostrum is responsible for lowering BRD risk, and the 
effect of CR on the severity of lobar consolidation in 
calves.
Although the intervention of CR did not reduce the 
odds of diarrhea in our calves, preventative feeding 
of extended colostrum to calves during the first 14 d 
of life has been found to reduce the risk of diarrhea 
(Chamorro et al., 2017; Kargar et al., 2020). Specifi-
cally, colostrum fed for 14 d reduced odds of diarrhea, 
number of days sick with diarrhea, and number of 
antibiotic treatment days received compared with con-
trols (Berge et al., 2009). Similarly, feeding 750 mL of 
lipolyzed bovine colostrum fed at 24 h of life reduced 
incidence of diarrhea in calves, although this was not 
seen in older calves at 48 or 72 h of life (Dezfouli et al., 
2007). Moreover, others found that preventative feed-
ing with colostrum for 21 d reduced the likelihood of 
diarrhea for the first 180 d of life (Armengol and Fraile, 
2020). Our results likely differed from other studies in 
not affecting diarrhea likelihood because we did not 
feed CR for a long duration. Instead, we fed our calves 
one dose of CR (containing 150 g of IgG) at a shorter 
interval and our calves were much older (i.e., a month 
old at the time of intervention). Calves are most at 
risk for diarrhea from birth until approximately 14 d of 
age, when passive immunity provided from colostrum 
is low (Cortese, 2009), or until 21 d of age when innate 
immunity is naive against endemic pathogens such as 
protozoans (as reviewed by Cho and Yoon, 2014). Be-
cause we chose to provide the AMF a 12-d acclimation 
period for an algorithm to establish an average, it is 
possible we missed the high-risk period for diarrhea in 
our calves. Future research should determine if younger 
calves receiving an AMF-based colostrum intervention 
would lower the risk of diarrhea.
We did not observe an effect of CR on ADG in this 
study. For this study, the CR and milk replacer offered 
had very similar levels of gross energy. However, our 
findings disagreed with the limited literature about 
extended colostrum feeding to calves and performance. 
Research has shown that extended feeding of colostrum 
by partially replacing the milk fed diet for 14 d with 
either 0, 350, or 700 g/d colostrum can improve per-
formance in calves postweaning (Kargar et al., 2020). 
Similarly feeding calves by partially replacing the milk 
meal with colostrum (2.3 L) for the first 21 d of life, 
resulted in greater first lactation body weights, though 
early life weights were not recorded (Armengol and 
Fraile, 2020). Finally, in parallel, work that investigated 
the effects of lactoferrin, a component of colostrum, 
did not observe an effect of lactoferrin on performance 
in calves (English et al., 2007; Pempek et al., 2018). 
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Table 2. Proportion of calves with a diarrhea bout after triggering an alarm on an automated feeder for 
negative deviations in milk intake or drinking speed 14 d following intervention by a treatment1
Stratum  Treatment2 Total Failed Censored Censored, %
1 Placebo 42 27 15 35.7
2 Colostrum replacer 42 22 20 47.6
Total  84 49 35 41.7
1Censored calves remained healthy at 15 d, and failed calves were diagnosed with a diarrhea bout within 14 d 
following intervention.
2Placebo = 125 g of placebo milk replacer (Cows Match, Land O’Lakes Inc.) in 1 L of water for 3 d; CR = 125 
g of colostrum replacer (Premolac Plus, Zinpro) in 1 L of water for 3 d.
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Thus, the literature suggests that calves fed colostrum 
for extended periods had positive average daily gain 
effects. Our results may have disagreed with these stud-
ies because we fed a much lower dose of colostrum for 
a shorter duration (i.e., 125 g for 3 d). Alternatively, 
it is possible that we did not find an effect of CR on 
ADG because the placebo calves received milk replacer 
that contained similar and even slightly more gross 
energy than the CR, a study design difference from oth-
ers who partially replaced the milk diet, or compared 
with a negative control. Thus, in our study, ADG was 
not affected in CR fed calves when the placebo calves 
received a high energy milk replacer. Future research 
should investigate if CR at this dosage compared with 
a negative control positively affects ADG in calves.
We acknowledge that one of the limitations of our 
study was that our researchers were not blind to treat-
ment assignments after the colostrum or placebo feed-
ings. Similarly, the AMF alarm used in this trial has 
not been previously used as a proxy for intervention in 
dairy calves. We encourage future work to investigate 
the utilization of different alarms as proxy for treat-
ments in dairy calves. Nonetheless, preventing BRD by 
intervening with CR when an AMF alarm is detected 
may improve the welfare of calves.
In summary, we observed that colostrum supple-
mentation during a negative deviation in average milk 
intake and drinking speed resulted in reduced likeli-
hood for the calf to develop BRD in the following 14 
d, but there was no effect on development of diarrhea 
or performance over this period. Although colostrum in 
our study did not reduce the likelihood of diarrhea, our 
calves triggered alarms at a month of age and were past 
the at-risk period for pathogenic diarrhea. Although 
we observed an effect of CR to ameliorate and reduce 
the likelihood of BRD, future research should attempt 
to disentangle and identify the influence of each fac-
tor present in colostrum such as the IgG, lactoferrin 
or another component that is actually responsible for 
improved respiratory health in older calves. Similarly, 
a lack of effect of colostrum on performance was likely 
a result of a high plane of nutrition being offered to 
the calves. Alternatively, it is possible that ADG was 
compromised by sick calves on this study due to anti-
biotic intervention. Colostrum many ameliorate BRD 
in preweaning calves, and the use of an AMF negative 
deviation in feed intake may be a potential intervention 
tool.
CONCLUSIONS
Colostrum offered as a nutraceutical at 125 g/d for 
3 d (50 g of IgG/d) may ameliorate BRD bouts, and 
reduce the odds of BRD when offered to calves who 
change their feeding behavior. However, there was no 
effect of colostrum treatment on amelioration of diar-
rhea, which may be related to the older age at which 
calves were treated (i.e., at 1 mo. of age). There also 
was no effect of colostrum treatment on performance, 
perhaps because calves receiving the placebo milk re-
placer treatment received a similar level of gross en-
ergy. This study offers early evidence that colostrum 
intervention can improve calf health. Future work is 
required to determine which components in colostrum 
are most effective, and whether colostrum intervention 
at younger ages may also reduce diarrhea risk.
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